Description	Location in text
Participants (total number randomised, and for each group)
Site of surgery e.g. small bowel, large bowel, both
Pathology e.g. 10% malignant 90% benign
Setting/Location
Inclusion criteria
Exclusion criteria
Baseline imbalances
Were the groups treated identical except for the named interventions?
Withdrawals and exclusions
Age (median, interquartile range)
Sex Male:Female
Race/Ethnicity
Specific surgery types
Severity of illness Dukes(A‐D) TNM		F
Co‐morbidities (e.g. diabetes mellitus)
Subgroups reported (e.g. laparoscopic vs. open surgery)
Study groups not included in review comparison (e.g. placebo groups, alternate treatment groups)
Sample size/Power calculations
Study start date to end date
Primary outcome e.g. length of hospital stay
ERAS protocol used?
Number of NG tube reinserted
Ethics
Notes: